Source:http://linkedlifedata.com/resource/pubmed/id/19838123
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-11-25
|
pubmed:abstractText |
Determination of HIV-1 subtype may be important in the management of HIV-infected individuals, particularly with regard to deciding the CD4 cell count at which to initiate antiretroviral therapy. Non-B subtypes, A and D, are prevalent in Uganda, and individuals infected with subtype D seem to have faster disease progression compared with those infected with subtype A. We examined the level of apoptosis in CD4+ T cells in a study cohort of volunteers infected with subtypes A and D infection. Although the levels of apoptosis in the activated CD4+ cells significantly decreased with viral suppression, CD4+ apoptosis in individuals infected with subtype D were found to be significantly higher compared with those infected with subtype A before antiretroviral treatment. Surface expression of PD-1 on CD4 cells in subtype D was substantially higher compared with that in subtype A (P = 0.03). This difference was not observed in the CD8 population (P > 0.05). Our findings suggest that the infecting HIV subtypes exert an independent influence on the disease outcome in response to antiretroviral treatment.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Retroviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Apoptosis Regulatory Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/PDCD1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Programmed Cell Death 1 Receptor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1944-7884
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
548-52
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:19838123-Adult,
pubmed-meshheading:19838123-Anti-Retroviral Agents,
pubmed-meshheading:19838123-Antigens, CD,
pubmed-meshheading:19838123-Apoptosis,
pubmed-meshheading:19838123-Apoptosis Regulatory Proteins,
pubmed-meshheading:19838123-CD4 Lymphocyte Count,
pubmed-meshheading:19838123-CD4-Positive T-Lymphocytes,
pubmed-meshheading:19838123-Female,
pubmed-meshheading:19838123-HIV Infections,
pubmed-meshheading:19838123-HIV-1,
pubmed-meshheading:19838123-Humans,
pubmed-meshheading:19838123-Lymphocyte Activation,
pubmed-meshheading:19838123-Male,
pubmed-meshheading:19838123-Programmed Cell Death 1 Receptor,
pubmed-meshheading:19838123-Prospective Studies,
pubmed-meshheading:19838123-Treatment Outcome,
pubmed-meshheading:19838123-Uganda
|
pubmed:year |
2009
|
pubmed:articleTitle |
Infection with different hiv subtypes is associated with CD4 activation-associated dysfunction and apoptosis.
|
pubmed:affiliation |
California Department of Health Services, Richmond, CA 94804, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|